Table 2.
SNPs Showing Significant Associations With STDR/PDR
MAF | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Phenotype | Nearest Gene(s) | SNP | Position | A1 | A2 | Non-STDR | STDR | OR (95% CI) | P Value* | q-Value§ |
STDR | COL5A1 | rs59126004‡ | 9:137674341 | C | T | 0.17 | 0.14 | 0.84 (0.71–0.98) | 0.034 | 0.798 |
IGSF21-KLHDC7A | rs3007729 | 1:18795255 | T | C | 0.32 | 0.30 | 0.87 (0.77–0.99) | 0.034 | 0.798 | |
CREB5 | rs11765845 | 7:28391142 | A | G | 0.29 | 0.28 | 0.87 (0.76–0.99) | 0.036 | 0.798 | |
LOC728275-LOC728316 | rs227455† | 6:165478051 | C | T | 0.48 | 0.47 | 0.89 (0.79–0.99) | 0.048 | 0.798 | |
PDR | INSR | rs2115386† | 19:7196565 | C | T | 0.47 | 0.52 | 1.25 (1.06–1.47) | 5.65 × 10−3 | 0.190 |
UBE2E2 | rs79941515‡ | 3:23225738 | T | C | 0.18 | 0.14 | 0.72 (0.57–0.91) | 6.75 × 10−3 | 0.190 | |
MYT1L-LOC729897 | rs10199521† | 2:2519513 | T | C | 0.35 | 0.39 | 1.24 (1.05–1.47) | 8.93 × 10−3 | 0.190 | |
COL5A1 | rs59126004‡ | 9:137674341 | C | T | 0.17 | 0.13 | 0.73 (0.57–0.93) | 0.011 | 0.190 | |
ZNRF1 | rs17684886† | 16:75086875 | A | T | 0.47 | 0.43 | 0.82 (0.69–0.97) | 0.022 | 0.259 | |
IGSF21-KLHDC7A | rs3007729 | 1:18795255 | T | C | 0.32 | 0.29 | 0.81 (0.67–0.97) | 0.023 | 0.259 | |
AKAP11-FABP3P2 | rs117850847 | 13:42909215 | A | C | 0.06 | 0.04 | 0.65 (0.44–0.96) | 0.030 | 0.259 | |
CCDC68-TCF4 | rs12607567† | 18:52858659 | G | A | 0.47 | 0.44 | 0.83 (0.70–0.98) | 0.030 | 0.259 |
A1, minor allele; A2, major allele; MAF, minor allele frequency.
SNPs are ranked by P value. Chromosomal position corresponds with human reference genome hg19. OR corresponds with the minor allele.
Adjusted for age, sex, BMI, duration of diabetes, the presence of HTN, and HbA1c.
Independent FDR correction for each test.
Direction of effect consistent with original report.
Direction of effect not available in original report.